Leader
ELITE MEMBER
- Joined
- Sep 7, 2010
- Messages
- 29,159
- Reaction score
- 9
- Country
- Location
CDWP approves Rs980.352m for proposed projects of Khyber Medical University
Central Development Working Party (CDWP) has approved PC-1 worth Rs 980.352 million of the proposed projects of Khyber Medical University (KMU) Peshawar to establish Research Institute of Hematology, Hepatobiliary Pancreatic Surgery & Transplantation (RIHEHP) and Research Institute of Diabetology, Endocrinology & NCDs (RIDENC). Sponsoring Agency of this project is Higher Education Commission (HEC) Islamabad while execution, operation and maintenance will be carried out by KMU, it was revealed by Prof. Dr. Mohammad Hafiz Ullah Vice Chancellor KMU while chairing 18th meeting of all heads of institutes, departments and sections of KMU. He said that this mega projects were approved in the 23rd meeting of CDWP held under the chairmanship of Mr. Ahsan Iqbal Federal Minister for Planning & Development / Dy. Chairman Planning Commission of Pakistan at Islamabad.
Prof. Dr. Hafiz Ullah highlighted that RIHEHP and RIDENC will offer state of the art services of liver transplant for patients developing liver cancer and will treat complications of diabetes like ketoacidosis, renal, cardiac, eye and foot ulcers and will offer advanced interventional radiology services for peripheral angioplasty. The institutes can further look into the possibility of pancreatic transplant as a cure for diabetes in the future.
Both institutes will offer wonderful opportunity to train doctors, nurses and paramedics in prevention and treatment of communicable and non-communicable diseases. This will offer a platform for researchers to conduct research on etiology, prevention and dissemination of communicable and non-communicable diseases. Well-equipped pathology laboratories, clinical and epidemiological, Basic Genetic and Stem Cell research, and radiology services will be installed and will be shared by both the institutes. State of the art computer lab will also be established to meet the demand of all the students and faculty, he added.
The VC shared that RIDEDNC will have limited beds for treating complication of diabetes while RIHEHPT will be developed to offer liver transplant facilities and bone marrow transplant. He said approval of these projects is clear sign of trust and confidence over the KMU and its projects by relevant organizations. It is worth mentioning that the aforesaid facilities will be made available to public through minimum user charges and financial support of Government of Khyber Pakhtunkhwa.
Central Development Working Party (CDWP) has approved PC-1 worth Rs 980.352 million of the proposed projects of Khyber Medical University (KMU) Peshawar to establish Research Institute of Hematology, Hepatobiliary Pancreatic Surgery & Transplantation (RIHEHP) and Research Institute of Diabetology, Endocrinology & NCDs (RIDENC). Sponsoring Agency of this project is Higher Education Commission (HEC) Islamabad while execution, operation and maintenance will be carried out by KMU, it was revealed by Prof. Dr. Mohammad Hafiz Ullah Vice Chancellor KMU while chairing 18th meeting of all heads of institutes, departments and sections of KMU. He said that this mega projects were approved in the 23rd meeting of CDWP held under the chairmanship of Mr. Ahsan Iqbal Federal Minister for Planning & Development / Dy. Chairman Planning Commission of Pakistan at Islamabad.
Prof. Dr. Hafiz Ullah highlighted that RIHEHP and RIDENC will offer state of the art services of liver transplant for patients developing liver cancer and will treat complications of diabetes like ketoacidosis, renal, cardiac, eye and foot ulcers and will offer advanced interventional radiology services for peripheral angioplasty. The institutes can further look into the possibility of pancreatic transplant as a cure for diabetes in the future.
Both institutes will offer wonderful opportunity to train doctors, nurses and paramedics in prevention and treatment of communicable and non-communicable diseases. This will offer a platform for researchers to conduct research on etiology, prevention and dissemination of communicable and non-communicable diseases. Well-equipped pathology laboratories, clinical and epidemiological, Basic Genetic and Stem Cell research, and radiology services will be installed and will be shared by both the institutes. State of the art computer lab will also be established to meet the demand of all the students and faculty, he added.
The VC shared that RIDEDNC will have limited beds for treating complication of diabetes while RIHEHPT will be developed to offer liver transplant facilities and bone marrow transplant. He said approval of these projects is clear sign of trust and confidence over the KMU and its projects by relevant organizations. It is worth mentioning that the aforesaid facilities will be made available to public through minimum user charges and financial support of Government of Khyber Pakhtunkhwa.
